Another study indicated that the average weight loss at week 68 ranged from 9.6% to 17.4%
Health care professionals and patients should report adverse events or side effects related to the use of this product to FDA's MedWatch Safety Information and Adverse Event Reporting Program: Complete and submit the report online MedWatch Online Voluntary Reporting Form, or: Download and complete the form, then submit it via fax at 1-800-FDA-0178
Until then, clinicians should continue evidence-based practice and keep an eye on the evolving science
adults has nearly quadrupled since 2024 putting employers in a tough spot: cover the medications and risk unsustainable healthcare costs, or don't and risk losing talent to companies that do
Patients should feel empowered to discuss their health goals, treatment plans, and any concerns about weight management with their healthcare team
It is important to distinguish between a direct pharmacological effect and secondary causes of dry mouth that may coincide with semaglutide treatment